To include your compound in the COVID-19 Resource Center, submit it here.

AstraZeneca, French National Institute of Health and Medical Research (INSERM) deal

AstraZeneca's MedImmune LLC subsidiary partnered with INSERM's

Read the full 76 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE